On Jan. 28, 2021, Precipio announced that following receipt of an Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) by Nirmidas Biotech, the developer and manufacturer of the COVID-19 antibody test. Precipio had begun to roll out these tests to the market.